产品名称 IDH1 R132H Antibody from DIANOVA GmbH
产品货号 DIA-H09
产品价格 现货询价,电话:010-67529703
产品规格 500 µl
产品品牌 DIANOVA GmbH
产品概述
产品详情
Edit&nbsp
Antigenic SpecificityIDH1 R132H
CloneH09
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG2a
Formatpurified
Size500 µl
Concentrationn/a
ApplicationsIHC, Paraffin Sections (FFPE), Western Blot
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionMarker for brain-tumor diagnosis (Astrocytoma, Oligidendroglioma), CE IVD. Antibody clone H09 reacts specifically with the isocitrate dehydrogenase 1 (IDH1) R132H point mutation in tissue sections from formalin-fixed brain tumor specimens. Heterozygous point mutations of IDH1 codon 132 are frequent in World Health Organization (WHO) grade II and III gliomas. IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. The high frequency and distribution of the IDH1 R132H mutation among specific brain tumor entities allow the highly sensitive and specific discrimination of various tumors by immunohistochemistry, such as anaplastic astrocytoma from primary glioblastoma or diffuse astrocytoma WHO grade II from pilocytic astrocytoma or ependymoma. Noteworthy is the discrimination of the infiltrating edge of tumors with IDH1 mutation from reactive gliosis. This antibody is highly useful for tumor classification and in detecting single infiltrating tumor cells.
ImmunogenSynthetic peptide, amino acid sequence CKPIIIGHHAYGD
Other NamesIDH1 R132H, isocitrate dehydrogenase 1 R132H point mutation
Gene, Accession #IDH1, 3417
Catalog #DIA-H09
Price
Order / More InfoIDH1 R132H Antibody from DIANOVA GmbH
Product Specific ReferencesMonoclonal antibody specific for IDH1 H132R mutation.Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A. Acta Neuropathol. 118(5): 599-601, 2009. / Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Capper D, Weissert S, Balss J, Habel A, Meyer J, Jager D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A.Brain Pathol. 20(1): 245-254, 2010. / Application of mutant IDH1 anti-body to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J. Am J Surg Pathol. 34(8):1199-1204, 2010.
产品资料